30-year follow-up of an unoperated left atrial myxoma: a case report

Zeinelabdien Elsherif1,2,3, Naveed Mahmood2,3,4, Amjad M Ahmed1,2,3

  • 1King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guard Health Affairs, PO Box 22490, Riyadh 11426, Saudi Arabia.

Insights

This study followed an unoperated left atrial myxoma for 30 years. The cardiac tumor naturally became smaller and more calcified over time, offering insights into cardiac myxoma progression.

Area of Science:

  • Cardiology
  • Oncology

Background:

  • Cardiac myxomas are the most common primary cardiac tumors, typically benign.
  • They often present with stroke, valve obstruction, or vague symptoms.
  • Surgical resection is the standard treatment.

Purpose of the Study:

  • To describe the natural history of an unoperated left atrial myxoma.
  • To observe the long-term progression of a cardiac myxoma.
  • To investigate the growth rate and changes in cardiac myxomas prior to surgical intervention.

Main Methods:

  • A case report of a 56-year-old female with a left atrial mass.
  • Diagnosis confirmed via transthoracic and transesophageal echocardiography.
  • Long-term follow-up for nearly 30 years using cardiac magnetic resonance imaging.

Main Results:

  • The left atrial mass, confirmed as myxoma, was initially recommended for surgical removal.
  • The patient opted for conservative management and was monitored for three decades.
  • Over 30 years, the myxoma significantly decreased in size and became more calcified.

Conclusions:

  • Cardiac myxomas exhibit heterogeneous growth rates, with limited data on unoperated tumors.
  • This case demonstrates that a left atrial myxoma can spontaneously regress and calcify over a long period.
  • The natural progression of cardiac myxomas may involve size reduction and calcification without surgical intervention.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...